These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4596992)

  • 21. The antileukemic effect of systemic non-specific BCG-immunostimulation vs systemic specific immunostimulation with irradiated isogeneic leukemic cells.
    Olsson L; Ebbesen P; Kiger N; Florentin I; Mathé G
    Eur J Cancer (1965); 1978 Apr; 14(4):355-62. PubMed ID: 348478
    [No Abstract]   [Full Text] [Related]  

  • 22. Prophylactic and therapeutic application of interferon in spontaneous leukemia in AKR mice.
    Bekesi JG; Roboz JP
    Tex Rep Biol Med; 1981-1982; 41():614-20. PubMed ID: 6189228
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of dose and route of Bacillus Calmette-Guérin in chemoimmunostimulation therapy of a murine leukemia.
    Pearson JW; Chaparas SD; Chirigos MA
    Cancer Res; 1973 Aug; 33(8):1845-8. PubMed ID: 4720796
    [No Abstract]   [Full Text] [Related]  

  • 24. Suppression of tumor growth and regression of established tumor with oil-attached mycobacterial fractions.
    Yamamura Y; Azuma I; Taniyama T; Ribi E; Zbar B
    Gan; 1974 Apr; 65(2):179-81. PubMed ID: 4209836
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of drug therapy against a histologically defined rat leukemia.
    Pearson JW; Chaparas SD; Torgersen JA; Perk K; Chirigos MA; Sher NA
    Cancer Res; 1974 Feb; 34(2):355-61. PubMed ID: 4589956
    [No Abstract]   [Full Text] [Related]  

  • 26. Active immunotherapy in spontaneous leukemia of AkR mice.
    Mathé G; Halle-Pannenko O; Bourut C
    Exp Hematol; 1973; 1(2):110-4. PubMed ID: 4609352
    [No Abstract]   [Full Text] [Related]  

  • 27. Graft versus leukemia. VI. Adoptive immunotherapy in combination with chemoradiotherapy for spontaneous leukemia-lymphoma in AKR mice.
    Bortin MM; Rose WC; Truitt RL; Rimm AA; Saltzstein EC; Rodey GE
    J Natl Cancer Inst; 1975 Nov; 55(5):1227-9. PubMed ID: 1546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of androgens on the development of leukemia in AKR-strain mice].
    Lisukov IA; Tsyrlova IG; Kozlov VA
    Eksp Onkol; 1986; 8(1):71-3, 79. PubMed ID: 3753930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyadenylic:polyuridylic acid-induced protection of BALB/c mice against acute murine cytomegalovirus infection.
    Adams A; Mohrman M; Johnson AG; Morin A; Deschamps de Paillette E
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2409-13. PubMed ID: 1328496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of synthetic polyribonucleotides on EL-4 lymphoma.
    Winchurch RA; Gibson R; Godla G; Mardiney MR
    J Reticuloendothel Soc; 1975 Oct; 18(4):244-51. PubMed ID: 1202222
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adjuvant immunotherapy using polyadenylic acid and polyuridylic acid (Poly A., Poly U.) in operable carcinoma of the breast (author's transl)].
    Lacour F; Lacour J; Spira A; Michelson M; Petit JY; Delage G; Contesso G; Merlin-Nahon E; Sarrazin D; Viguier J
    Chirurgie; 1980 Nov; 106(9):737-43. PubMed ID: 7009093
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunology of brain tumors (author's transl)].
    Takakura K
    No To Shinkei; 1976 Jun; 28(6):525-37. PubMed ID: 194610
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined chemoimmunotherapy of L5178Y lymphoma.
    Balázová E; Koza I; Ujházy V
    Neoplasma; 1978; 25(6):653-7. PubMed ID: 752113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy of human leukemia.
    Baker MA; Taub RN
    Mt Sinai J Med; 1972; 39(6):548-65. PubMed ID: 4565179
    [No Abstract]   [Full Text] [Related]  

  • 35. [Adjuvant immunotherapy with polyadenylic-polyuridylic acid (Poly A.Poly U) in operable cancer of the breast. Recent results of a controlled therapeutic trial].
    Lacour J; Lacour F; Spira A; Michelson M; Petit JY; Delage G; Sarrazin D; Contesso G; Viguier J
    Chirurgie; 1984; 110(4):418-24. PubMed ID: 6389040
    [No Abstract]   [Full Text] [Related]  

  • 36. L2C leukemia: a model of human acute leukemia.
    Murphy SG; LoBuglio AF
    Fed Proc; 1977 Aug; 36(9):2281-5. PubMed ID: 328309
    [No Abstract]   [Full Text] [Related]  

  • 37. An experimental model of active immunotherapy preceded by cytoreductive chemotherapy.
    Amiel JL; Berardet M
    Eur J Cancer (1965); 1970 Dec; 6(6):557-9. PubMed ID: 4926872
    [No Abstract]   [Full Text] [Related]  

  • 38. A new adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer.
    Lacour F; Lacour J; Spira A; Michelson M; Delage G; Petit JY; Viguier J
    Recent Results Cancer Res; 1982; 80():200-6. PubMed ID: 7036283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abrogation of the tumor promoting effect of allogeneic blood transfusion by polyadenylic-polyuridylic acid (poly A-poly U).
    Singh SK; Marquet RL; Westbroek DL; Jeekel J
    Cancer Immunol Immunother; 1987; 25(3):242-4. PubMed ID: 3677125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer: updated results of a randomised trial.
    Lacour J; Lacour F; Spira A; Michelson M; Petit JY; Delage G; Sarrazin D; Contesso G; Viguier J
    Br Med J (Clin Res Ed); 1984 Feb; 288(6417):589-92. PubMed ID: 6421391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.